|INFLUENZA VACCINE RECOMMENDATIONS: ALLERGIES|
All vaccination providers should be familiar with the office emergency plan and have current certification in cardiopulmonary resuscitation. Epinephrine and emergency equipment for airway maintenance must be readily available for immediate use.
|VACCINE CONTRAINDICATIONS AND PRECAUTIONS|
|Vaccine† associated with previous severe allergic reaction|
|Any egg-based IIV or LAIV||Contraindication||Precaution*||Precaution*|
|Unknown influenza vaccine||Consult with allergist|
Key: ccIIV4 = Cell Culture-based Inactivated Influenza Vaccine, Quadrivalent; IIV4 = Inactivated Influenza Vaccine, Quadrivalent; LAIV4 = Live Attenuated Influenza Vaccine, Quadrivalent; RIV4 = Recombinant Influenza Vaccine, Quadrivalent
* Vaccination should generally be deferred but might be indicated if the benefit of protection from the vaccine outweighs the risk for an adverse reaction. Providers can consider vaccination but should occur in an inpatient or outpatient medical setting under the supervision of a health care provider who is able to recognize and manage severe allergic reactions. Providers can also consider consulting with an allergist to help determine which vaccine component is responsible for the allergic reaction.
† Vaccine of any valency (eg, trivalent, quadrivalent)
Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season. MMWR Recomm Rep. 2021;70(No. RR-5):1–28. DOI: http://dx.doi.org/10.15585/mmwr.rr7005a1.